|
mutLBSgeneDB |
| |
| |
| |
| |
| |
| |
|
| Gene summary for KDM6A |
 Gene summary |
| Basic gene Info. | Gene symbol | KDM6A |
| Gene name | lysine (K)-specific demethylase 6A | |
| Synonyms | KABUK2|UTX|bA386N14.2 | |
| Cytomap | UCSC genome browser: Xp11.2 | |
| Type of gene | protein-coding | |
| RefGenes | NM_001291415.1, NM_001291416.1,NM_001291417.1,NM_001291418.1,NM_001291421.1, NM_021140.3,NR_111960.1, | |
| Description | bA386N14.2 (ubiquitously transcribed X chromosome tetratricopeptide repeat protein (UTX))histone demethylase UTXlysine-specific demethylase 6Aubiquitously transcribed tetratricopeptide repeat protein X-linkedubiquitously-transcribed TPR gene on the X | |
| Modification date | 20141222 | |
| dbXrefs | MIM : 300128 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000147050 | ||
| HPRD : 02131 | ||
| Vega : OTTHUMG00000021402 | ||
| Protein | UniProt: O15550 go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_KDM6A | |
| BioGPS: 7403 | ||
| Pathway | NCI Pathway Interaction Database: KDM6A | |
| KEGG: KDM6A | ||
| REACTOME: KDM6A | ||
| Pathway Commons: KDM6A | ||
| Context | iHOP: KDM6A | |
| ligand binding site mutation search in PubMed: KDM6A | ||
| UCL Cancer Institute: KDM6A | ||
| Assigned class in mutLBSgeneDB | B: This gene belongs to targetable_mutLBSgenes. | |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO Term | PubMed ID |
| Top |
| Ligand binding site mutations for KDM6A |
| Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.)  : non-synonymous mutation on LBS, Circle size denotes number of samples. |
 |
| Cancer type specific mutLBS sorted by frequency |
| LBS | AAchange of nsSNV | Cancer type | # samples | G1191 | G1191C | LUAD | 1 | G1321 | G1321W | LUAD | 1 | R1322 | R1322Q | SKCM | 1 | I1267 | P1269S | SKCM | 1 | L1342,V1344 | F1343C | UCEC | 1 |
| cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
| Top |
| Protein structure related information for KDM6A |
| Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
 : nsSNV at non-LBS : nsSNV at LBS |
 |
| nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
| LBS | AAchange of nsSNV | Relative stability change | V1344 | F1343C | -1.1457365 | L1342 | F1343C | -1.1457365 | I1267 | P1269S | -1.1276585 | R1322 | R1322Q | -0.87467155 | G1191 | G1191C | -0.7620147 | G1321 | G1321W | -0.14039977 |
| (MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
| Structure image for KDM6A from PDB |
| Top |
| Differential gene expression and gene-gene network for KDM6A |
| Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
| Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
| Top |
| Top |
| Phenotype information for KDM6A |
| Gene level disease information (DisGeNet) |
| Disease ID | Disease name | # PubMed | Association type |
| umls:C0010606 | Carcinoma, Adenoid Cystic | 1 | Biomarker |
| umls:C0007138 | Carcinoma, Transitional Cell | 1 | Biomarker |
| umls:C0279626 | Esophageal Squamous Cell Carcinoma | 1 | Biomarker |
| umls:C0027651 | Neoplasms | 1 | Biomarker |
| umls:C0005695 | Urinary Bladder Neoplasms | 1 | Biomarker |
| Mutation level pathogenic information (ClinVar annotation) |
| Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
| Top |
| Pharmacological information for KDM6A |
| Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
 |
| Drug information targeting mutLBSgene (Approved drugs only) |
| Drug status | DrugBank ID | Name | Type | Drug structure |
| Gene-centered ligand-gene interaction network |
 |
| Ligands binding to mutated ligand binding site of KDM6A go to BioLip |
| Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | III | Peptide ligand (ARG,LYS,GLN,LEU,ALA,THR,LYS,ALA,ALA,ARG,LYS,SER,ALA,PRO,ALA,THR,GLY) | 3avr | A | G1191 I1267 G1321 R1322 L1342 V1344 |
| Top |
| Conservation information for LBS of KDM6A |
| Multiple alignments for O15550 in multiple species |
| LBS | AA sequence | # species | Species |
 |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |